Skip to main content
. 2024 Apr 28;14(5):568. doi: 10.3390/life14050568

Table 2.

Characteristics of the whole sample and comparison of initial parameters in the group of responders and non-responders.

Initial Characteristics Entire Sample Responders Non-Responders p
Number of patients 59 42 17
Gender (% of women) 40 34 53 0.2537
Patients with BBI (% from entire sample) 78 81 71 0.4906
Age (years) 59.5 ± 9.5 60.2 ± 9.8 57.6 ± 9.1 0.2882
Body weight (kg) 106.0 ± 14.9 109.4 ± 13.6 97.7 ± 15.1 0.0172
BMI (kg/m2) 35.2 ± 4.5 35.7 ± 4.3 34.0 ± 5.2 0.1117
Duration of diabetes (years) 14.3 ± 6.2 15.0 ± 6.7 12.5 ± 4.5 0.2800
Duration of insulin therapy (years) 6.4 ± 5.0 6.5 ± 5.5 6.0 ± 3.8 0.9466
HbA1c (mmol/mol) 80.0 ± 20.5 75.6 ± 17.9 90.5 ± 23.6 0.0415
Insulin dose (IU/day) 74.3 ± 36.3 67.6 ± 36.4 90.8 ± 32.4 0.0235
Insulin dose (IU/kg/day) 0.72 ± 0.38 0.62 ± 0.33 0.96 ± 0.43 0.0057
Mean glycaemia during 72 h fasting test (mmol/L) 7.4 ± 2.0 6.9 ± 1.7 8.6 ± 2.2 0.0084
Mean glycaemia on the 1st day of fasting (mmol/L) 7.3 ± 2.0 6.8 ± 1.7 8.4 ± 2.2 0.0139
Mean glycaemia on the 2nd day of fasting (mmol/L) 7.5 ± 2.1 6.9 ± 1.8 8.8 ± 2.5 0.0064
Mean glycaemia on the 3rd day of fasting (mmol/L) 7.3 ± 2.3 6.8 ± 2.1 8.4 ± 2.5 0.0317

Data are presented as mean ± standard deviation.